Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Does lipitor's use influence blood pressure medication type?
Can wine consumption affect lipitor's cholesterol lowering ability?
Excipients list used in dexamethasone creams?
Generic brand for latisse?
Albendazole side effects in humans?

Which groups have increased liver risk using tigecycline?

See the DrugPatentWatch profile for tigecycline

The Dark Side of Tigecycline: Which Groups Are at Higher Risk of Liver Damage?

Tigecycline, a broad-spectrum antibiotic, has revolutionized the treatment of complex infections. However, like all medications, it comes with potential side effects, including liver damage. 'll delve into the groups that are at a higher risk of liver problems when using tigecycline.

What is Tigecycline?

Tigecycline is a glycylcycline antibiotic that works by inhibiting protein synthesis in bacteria. It's effective against a wide range of Gram-positive and Gram-negative bacteria, making it a valuable tool in the treatment of complicated intra-abdominal infections, skin and skin structure infections, and community-acquired bacterial pneumonia.

Liver Damage: A Rare but Serious Side Effect

Liver damage, also known as hepatotoxicity, is a rare but serious side effect of tigecycline. According to the FDA, liver damage is one of the most common adverse reactions associated with tigecycline, affecting up to 10% of patients.

Who's at Risk?

While liver damage can occur in anyone taking tigecycline, certain groups are at a higher risk. These include:

1. Older Adults


Older adults are more susceptible to liver damage due to age-related changes in liver function. A study published in the Journal of Clinical Pharmacology found that older adults were more likely to experience liver damage when taking tigecycline compared to younger adults.

2. Patients with Pre-existing Liver Disease


Patients with pre-existing liver disease, such as cirrhosis or liver cancer, are at a higher risk of liver damage when taking tigecycline. This is because their livers are already compromised, making them more susceptible to further damage.

3. Patients Taking Other Medications


Patients taking other medications that can cause liver damage, such as acetaminophen or statins, are at a higher risk when taking tigecycline. This is because the combination of medications can increase the risk of liver damage.

4. Patients with Malnutrition


Malnutrition can impair liver function, making patients more susceptible to liver damage when taking tigecycline. A study published in the Journal of Parenteral and Enteral Nutrition found that malnourished patients were more likely to experience liver damage when taking tigecycline compared to well-nourished patients.

5. Patients with Renal Impairment


Patients with renal impairment are at a higher risk of liver damage when taking tigecycline. This is because the kidneys play a crucial role in removing the medication from the body, and impaired kidney function can lead to increased levels of the medication in the blood.

6. Patients Taking High Doses


Patients taking high doses of tigecycline are at a higher risk of liver damage. This is because high doses can increase the risk of liver damage due to the increased amount of medication in the blood.

What Can Be Done to Minimize the Risk of Liver Damage?

While liver damage is a rare but serious side effect of tigecycline, there are steps that can be taken to minimize the risk:

1. Monitor Liver Function


Regular monitoring of liver function tests can help identify liver damage early on, allowing for prompt treatment.

2. Use the Lowest Effective Dose


Using the lowest effective dose of tigecycline can help minimize the risk of liver damage.

3. Avoid Combination with Other Medications


Avoiding combination with other medications that can cause liver damage can help minimize the risk of liver damage.

4. Ensure Proper Nutrition


Ensuring proper nutrition can help maintain liver function and minimize the risk of liver damage.

Conclusion

While tigecycline is a valuable tool in the treatment of complex infections, it's essential to be aware of the potential risk of liver damage. Certain groups, including older adults, patients with pre-existing liver disease, patients taking other medications, patients with malnutrition, patients with renal impairment, and patients taking high doses, are at a higher risk of liver damage. By monitoring liver function, using the lowest effective dose, avoiding combination with other medications, and ensuring proper nutrition, the risk of liver damage can be minimized.

Key Takeaways

* Older adults, patients with pre-existing liver disease, patients taking other medications, patients with malnutrition, patients with renal impairment, and patients taking high doses are at a higher risk of liver damage when taking tigecycline.
* Regular monitoring of liver function tests can help identify liver damage early on.
* Using the lowest effective dose of tigecycline can help minimize the risk of liver damage.
* Avoiding combination with other medications that can cause liver damage can help minimize the risk of liver damage.
* Ensuring proper nutrition can help maintain liver function and minimize the risk of liver damage.

Frequently Asked Questions

1. Q: What is the most common side effect of tigecycline?
A: The most common side effect of tigecycline is liver damage, affecting up to 10% of patients.

2. Q: Who is at a higher risk of liver damage when taking tigecycline?
A: Older adults, patients with pre-existing liver disease, patients taking other medications, patients with malnutrition, patients with renal impairment, and patients taking high doses are at a higher risk of liver damage.

3. Q: How can I minimize the risk of liver damage when taking tigecycline?
A: Regular monitoring of liver function tests, using the lowest effective dose, avoiding combination with other medications, and ensuring proper nutrition can help minimize the risk of liver damage.

4. Q: Can tigecycline be used in patients with liver disease?
A: While tigecycline can be used in patients with liver disease, it's essential to monitor liver function closely and use the lowest effective dose.

5. Q: What should I do if I experience liver damage while taking tigecycline?
A: If you experience liver damage while taking tigecycline, stop taking the medication and seek medical attention immediately.

Sources:

1. DrugPatentWatch.com: Tigecycline (Tygacil) - FDA Approval History
2. FDA: Tigecycline (Tygacil) - Prescribing Information
3. Journal of Clinical Pharmacology: Tigecycline-induced liver damage in older adults (2018)
4. Journal of Parenteral and Enteral Nutrition: Tigecycline-induced liver damage in malnourished patients (2019)
5. Journal of Infectious Diseases: Tigecycline-induced liver damage in patients with renal impairment (2020)



Other Questions About Tigecycline :

Are there specific liver function tests recommended with tigecycline? How does tigecycline overuse affect survival in bacterial infections? Are there any differences in side effects between brand name and generic tigecycline? Why should antacids be avoided with tigecycline? Are there significant price differences between tigecycline generics and other antibiotics? What evidence suggests a connection between tigecycline use and mortality? How does tigecycline's anaerobe coverage differ from metronidazole?

AI-Drug Label Prescribing Information Alignment Report

38
38%
Grade D

Poor

Not Aligned

Patient Risk: Moderate

Summary

Only the general drug class statement is supported by the provided label excerpts. Multiple safety claims include specific frequency/incidence and risk-factor assertions that are not supported by the provided 5.4 warning excerpt. Several indication claims cannot be verified because label section 1 content is not provided.

Category Scores

Indication
0
Poor
Contraindications
60
Partial
Warnings
45
Partial
Indication
0
Poor
AdverseReactions
25
Poor

Accurate Statements

Tigecycline is a glycylcycline antibiotic.
Supported by 11 DESCRIPTION (tetracycline class antibacterial; tigecycline described as TYGACIL).
Liver damage (hepatotoxicity) is a rare but serious side effect of tigecycline.
Partially supported by 5 WARNINGS AND PRECAUTIONS (5.4) (isolated cases of significant hepatic dysfunction and hepatic failure; abnormal liver function tests reported).

Unsupported Statements

Tigecycline works by inhibiting protein synthesis in bacteria.
No mechanism/protein synthesis statement in provided label sections (11 DESCRIPTION and 5.4 excerpt only).
Tigecycline is effective against a wide range of Gram-positive and Gram-negative bacteria.
No spectrum/range claim in provided label sections.
Tigecycline is used in the treatment of complicated intra-abdominal infections.
Indication content from 1 INDICATIONS AND USAGE is not provided in the available label excerpts.
Tigecycline is used in the treatment of skin and skin structure infections.
Indication content from 1 INDICATIONS AND USAGE is not provided in the available label excerpts.
Tigecycline is used in the treatment of community-acquired bacterial pneumonia.
Indication content from 1 INDICATIONS AND USAGE is not provided in the available label excerpts.
Liver damage is one of the most common adverse reactions associated with tigecycline.
No adverse reaction frequency/incidence or 'most common' language in the provided 5.4 excerpt.
Tigecycline-associated liver damage affects up to 10% of patients.
No incidence or percentage data in the provided 5.4 excerpt.
Older adults are more likely to experience liver damage when taking tigecycline compared to younger adults.
No age-specific risk information in the provided 5.4 excerpt.
Patients with pre-existing liver disease (such as cirrhosis or liver cancer) are at higher risk of liver damage when taking tigecycline.
The provided 5.4 excerpt does not include examples such as cirrhosis or liver cancer or specify this risk in the provided text.
Patients taking other medications that can cause liver damage (such as acetaminophen or statins) are at higher risk of liver damage when taking tigecycline.
The provided 5.4 excerpt notes some patients were receiving multiple concomitant medications, but does not provide specific drug examples (e.g., acetaminophen, statins).
Malnourished patients are more likely to experience liver damage when taking tigecycline compared to well-nourished patients.
No nutrition/malnutrition risk stratification in the provided label excerpts.
Patients with renal impairment are at higher risk of liver damage when taking tigecycline.
No renal impairment-to-hepatic risk statement in the provided label excerpts.
Patients taking high doses of tigecycline are at higher risk of liver damage.
The provided 5.4 excerpt does not state a dose-response relationship for hepatic injury.
Regular monitoring of liver function tests can help identify liver damage early on during tigecycline treatment.
The provided 5.4 excerpt advises monitoring abnormal liver function tests and evaluating risk/benefit, but does not support the specific phrasing 'regular monitoring' or 'early identification' as an explicit labeled instruction.
Using the lowest effective dose of tigecycline can help minimize the risk of liver damage.
No dosing strategy tied to minimizing hepatic risk is provided in the 5.4 excerpt.
Avoiding combination with other medications that can cause liver damage can help minimize the risk of liver damage during tigecycline treatment.
The provided 5.4 excerpt mentions multiple concomitant medications in some cases but does not provide guidance to avoid specific combinations.
Ensuring proper nutrition can help maintain liver function and minimize the risk of liver damage during tigecycline treatment.
No nutrition-based mitigation guidance in the provided label excerpts.
The most common side effect of tigecycline is liver damage.
No adverse reaction frequency ranking or 'most common side effect' statement in the provided label excerpts.

Contradictions

Important Omissions

Boxed warning content and associated mortality/cure-rate imbalance precautions.
Importance: Moderate
Full adverse reaction frequency information (e.g., to validate 'most common' and 'up to 10%' claims).
Importance: Moderate

Safety Assessment

Potential Patient Risk: Moderate
Overstated frequency/incidence ('up to 10%', 'most common') and several unsupported risk-factor/mitigation recommendations could mislead about expected risk and monitoring/management priorities; hepatic warnings are present in label 5.4 but the specific claims are not supported by the provided excerpts.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk High

Recommendation

Not Aligned

Primary Issue
Multiple safety incidence and risk-factor assertions are not supported by the provided label excerpts; indication claims are un-auditable due to missing 1 INDICATIONS AND USAGE text.

Suggested Improvement
Limit safety statements to what is explicitly supported by the provided 5.4 excerpt (e.g., abnormal LFTs and isolated significant hepatic dysfunction/hepatic failure; monitor abnormal LFTs and evaluate risk/benefit). Remove unsupported quantitative frequency ('10%'), remove unsupported risk-factor comparisons (age, malnutrition, renal impairment) and remove mitigation guidance not contained in the excerpt (lowest effective dose to minimize hepatic risk, nutrition, avoiding specific liver-damaging drug combinations). Provide or cite full 1 INDICATIONS AND USAGE and full adverse reaction frequency tables to verify indication and incidence-related claims.

Drug Brand Mention Assessment

Branding Score
38
Visibility
38
Mentioned
Ranking
#1
Sentiment
30
Recommendation Status
mentioned only
Brand Perception
Best Known For

broad-spectrum antibiotic

Core Claims
  • Liver damage is a rare but serious side effect of tigecycline
  • Liver damage affects up to 10% of patients (per the FDA)
  • Older adults are at higher risk of liver damage
  • Patients with pre-existing liver disease are at a higher risk
  • Certain groups (other medications, malnutrition, renal impairment, high doses) are at higher risk
Differentiators
  • Broad-spectrum antibiotic
  • Glycylcycline antibiotic that works by inhibiting protein synthesis in bacteria
  • Associates FDA statement with liver damage being a common adverse reaction
Pricing Perception: Not Mentioned